Welcome back to Diagnosis, a vertical that focuses on the crossroads of health care policy and politics.
— PDLs and PBMs —
While things appear to be moving at lightning speed, a high priority for Gov. Ron DeSantis, cracking down on pharmacy benefit managers (PBMs) won’t be heard in the House or Senate until next week.
In the meantime, there’s an opportunity to examine how the Medicaid program, which provides coverage to more than 5.4 million people, decides which drugs it offers. The Florida Medicaid Pharmaceutical & Therapeutics (P&T) is scheduled to meet Friday. The 11-member committee comprises five physicians, five
Disclaimer: This article may require a subscription.